The benefit of repurposing drugs is precisely that we have decades of safety profile data. That's why those are particularly interesting against emerging diseas

The benefit of repurposing drugs is precisely that we have decades of safety profile data. That's why those are particularly interesting against emerging diseases, especially for low income countries. Obviously that's an issue for big pharma since they're not competitive when it comes to pure manufacturing of cheap drugs.